ECCT Malaysia

09/09/2025

More cancer guidance information can be read www.ecct-asia.com

09/09/2025

⚠️Doctors say: 70% of cancer patients share the same bad habit

Most people think cancer only comes from smoking, drinking, or poor diet

❌ But the truth is, many patients don’t even have these habits
So, what’s the hidden culprit❓

👉 Chronic lack of sleep💤

Here’s why sleep matters more than you think:
😴 Sleep is when your body repairs and recovers
🛡️ Without enough rest, your immune system weakens — your “defense wall” starts to crumble
🦠 Over time, the damage adds up, and the risk of cancer silently increases

Think about it:
Some people stay up until 2️⃣–3️⃣am, saying, “I’m still young, I can handle it”💪

But years later, they’re always tired, can’t focus, and tests show weak immunity

doctors call this “silent damage” — the perfect ground for disease🧑‍⚕️

How to protect yourself:
✅Sleep before 11 PM
✅Cut down screen time before bed
✅Create a dark, quiet sleep environment
✅Get 7️⃣-8️⃣ hours of quality sleep

Health isn’t lost overnight — it’s slowly stolen by habits like sleep deprivation💡

Your lifestyle today becomes your health tomorrow📅

Don’t underestimate sleep
Good sleep is the best medicine😴

09/09/2025

睾丸癌晚期转移后，还有另一条路吗❓

来自马来西亚的Khairul，今年3️⃣9️⃣岁

他右侧睾丸肿胀了六年，直到 2023 年才被确诊——睾丸癌，而且已经转移到肺部、淋巴结，甚至脊柱

他接受了4个周期的化疗（BEP 方案），起初肿瘤有缩小，但很快又复发，肿瘤指标 AFP 持续上升🔝
最终，医生只能停止化疗…

就在2025年春节期间，Khairul接触到 ECCT电场抗癌疗法，决定尝试作为新的治疗方式✨

经过5个月的治疗，他的情况发生了变化：
✅体重从52kg增加到59kg
✅贫血改善，血红素（Hb）回升
✅肝功能指标提升
✅AFP 从 11.3 降到 7.0，再到 5.5，如今接近正常值 4.7
✅整个过程没有出现新的痛苦或明显副作用

这意味着，ECCT 在控制睾丸癌的肺部和淋巴转移方面，带来了新的希🙏

Khairul 的案例也说明了
当传统治疗效果不再明显时，ECCT 可能是值得尝试的一条路径💪

#晚期癌症 #睾丸癌治疗

08/09/2025

Mr Khairul, 39-year-old male in Malaysia, had been dealing with a right testicular swelling for the past six years, which gradually increased in size. In November 2023, his condition worsened, and he sought medical attention at the Hospital. Imaging confirmed the diagnosis of right testicular carcinoma with metastasis to the lungs and lymph nodes, including large para-aortic nodes.

After careful consideration, he agreed to undergo chemotherapy (BEP regimen) after completing four cycles, his tumor size was reduced by a bit, and his overall condition stabilized, despite metastasis to the lungs and spine. Although he experience side effects such as fatigue and a reduced appetite, but there was no pain or bleeding. However, subsequent chemotherapy does not show further effect and his tumour continue to grow and tumour marker continue to rise. His oncology then stopped chemotherapy hereafter.

First Free Trial in JRX Global Centre
In Feb 2025 during Chinese New Year, he came across ECCT and decided to give it a try as the Alternative Treatment for Testicular Cancer. Prior to the initiation of ECCT, Khairul’s serum AFP levels were on an increasing trend, indicating active disease progression. His hemoglobin (HB) was also low, reflecting anemia likely due to tumor burden and previous chemotherapy effects.

Since beginning ECCT, now over five months, Khairul's condition has markedly improved. His body weight has stabilized and increased slightly from 52kg to 59kg, suggesting an improvement in general physical status. Even good news is, his recent blood tests show a significant decline in AFP levels from 11.3 to return normal at 7.0, continue to reduced to 5.5 and reaching 4.7 after near five month of the treatment, indicating a favorable response to the treatment by reducing tumor activity and metastasis.

Furthermore, his hemoglobin levels and albumin globulin ratio have risen, reflecting improved blood health, reduced anemia and improved liver function. Notably, he reports no new symptoms of pain or discomfort, along his treatment with ECCT.

This case exemplifies how ECCT can effectively contribute to controlling advanced metastatic testicular cancer, improving biochemical markers, and enhancing the patient’s quality of life. Khairul’s progress continues to be closely monitored, with ongoing assessments to optimize his treatment plan.

https://www.ecct-asia.com/post/alternative-treatment-for-testicular-cancer

07/09/2025

Europe, Mr. Bruno, 74 Years old, Male, Paris
Alternative Cancer Treatment for Stage 4 Prostate Cancer

In September 2023, at the age of 72, he was diagnosed with prostate cancer of the adenocarcinoma type, with a high Gleason score of 9/10. A PET scan revealed that the cancer cells had infiltrated the entire prostate gland, with metastasis to the lymph nodes in the pelvic area and around the aorta, as well as spread to various points in the pelvic bones. His condition was already at stage 4 at the time of diagnosis.

There were not many treatment options available for a case with such widespread metastasis. He previously opted to take hormone-suppressing medication, undergo Impedence based Electric Cancer Therapy in Germany, and take GcMAF immunotherapy supplements from Japan. After about a year of treatment, follow-up PET scans showed that the cancer had continued to spread—lymph node metastasis had reached the entire chest and neck area, and bone metastasis had extended to the skull. Meanwhile, the tumor mass had completely filled the prostate.

While he is about to give up, he was introduced to ECCT as Alternative Cancer Treatment for Stage 4 Prostate Cancer by a colleague who had used it earlier. ECCT uses capacitive electric fields (non-contact, without current or shock), while the treatment he done in Germany uses impedance-based electric fields that are applied to the skin and involve electrical current. For ECCT, he was recommended to covered full-body device covering from head to toe, as the cancer had spread to lymph nodes and bones—indicating that cancer cells had already entered the bloodstream and lymphatic system throughout the body.

He initially strongly refused to wear the ECCT helmet that covered his face and neck. Hence, he began only using the ECCT blanket in December 2024. During treatment, he experienced no serious complications. As long as the areas of spread were adequately covered and the dead cells could be expelled properly, even widespread metastasis could still be resolved completely.

After just six months of using ECCT, a follow-up PET scan showed that the cancer masses had been largely cleared from the prostate and all previously affected areas—including the lymph nodes from the pelvic area up to the chest and all affected bones—except for the face and neck, which he had refused to put on the helmet from the beginning. Upon seeing the PET scan results, he finally accepted to also put on ECCT helmet to cover his face and neck.

So far, his condition has remained stable—almost indistinguishable from normal health. He continues to work and travels actively around the world for business along with ECCT.

https://www.ecct-asia.com/post/ecct-as-an-alternative-cancer-treatment-for-stage-4-prostate-cancer

06/09/2025

More publications can be read www.ecct-asia.com/articles

05/09/2025